Afuco™ Anti-Human Ig VH1-69 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-Ig VH1-69 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a humanized monoclonal antibody that binds to the human immunoglobulin heavy chain variable region gerrnline gene VHI-69. The antibody is derived from Mab G6 and recognizes the same epitope. Moreover, the antibody is used in combination with vaccines to augment an immune response to microbial infection.
Supplier Creative Biolabs
Product # AFC-368CL
Pricing Inquiry
Host Humanized
Target Ig VH1-69
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback